Lipa Pharmaceuticals Ltd T/A Lipa Pharmaceuticals
[2022] FWCA 974
•21 MARCH 2022
| [2022] FWCA 974 |
| FAIR WORK COMMISSION |
| DECISION |
Fair Work Act 2009
s.185 - Application for approval of a single-enterprise agreement
Lipa Pharmaceuticals Ltd T/A Lipa Pharmaceuticals
(AG2021/9294)
Lipa Pharmaceuticals Ltd - Employee Collective Agreement 2021-2022.
| Pharmaceutical industry | |
| DEPUTY PRESIDENT CROSS | SYDNEY, 21 MARCH 2022 |
Application for approval of the Lipa Pharmaceuticals Ltd - Employee Collective Agreement 2021 - 2022
An application has been made for approval of an enterprise agreement known as the Lipa Pharmaceuticals Ltd - Employee Collective Agreement 2021 - 2022 (the Agreement). The application was made pursuant to s.185 of the Fair Work Act 2009 (the Act). It has been made by Lipa Pharmaceuticals Ltd. The Agreement is a single enterprise agreement.
The Employer has provided written undertakings. A copy of the undertakings is attached in Annexure A. I am satisfied that the undertakings will not cause financial detriment to any employee covered by the Agreement and that the undertakings will not result in substantial changes to the Agreement. The undertakings are taken to be a term of the agreement.
Subject to the undertakings referred to above, I am satisfied that each of the requirements of ss.186, 187, 188 and 190 as are relevant to this application for approval have been met.
The United Workers Union being a bargaining representative for the Agreement, has given notice under s.183 of the Act that it wants the Agreement to cover it. In accordance with s.201(2) I note that the Agreement covers the organisation.
The Agreement is approved and, in accordance with s.54 of the Act, will operate from seven days from the date of this approval. The nominal expiry date of the Agreement is 28 March 2023.
DEPUTY PRESIDENT
Printed by authority of the Commonwealth Government Printer
<AE515407 PR739488>
ANNEXURE A
0
0
0